These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 17676199

  • 1. The potential osteogenic effects of systemic leptin and insulin administration in streptozotocin-induced diabetic female rats.
    Gad HI.
    Saudi Med J; 2007 Aug; 28(8):1185-90. PubMed ID: 17676199
    [Abstract] [Full Text] [Related]

  • 2. The relationship between nitric oxide and leptin in the lung of rat with streptozotocin-induced diabetes.
    Oztay F, Kandil A, Gurel E, Ustunova S, Kapucu A, Balci H, Akgun-Dar K, Demirci C.
    Cell Biochem Funct; 2008 Aug; 26(2):162-71. PubMed ID: 17542037
    [Abstract] [Full Text] [Related]

  • 3. Effects of insulin and sulphonylureas on insulin-like growth factor-I levels in streptozotocin-induced diabetic rats.
    Guney E, Kisakol G, Oge A, Yilmaz C, Kabalak T.
    Neuro Endocrinol Lett; 2002 Aug; 23(5-6):437-9. PubMed ID: 12500166
    [Abstract] [Full Text] [Related]

  • 4. Effects of a Combination Therapy of Sclerostin Antibody III and Raloxifene on Bone Formation Markers in Ovariectomized Rats.
    Gad Allam HI.
    J Coll Physicians Surg Pak; 2016 Jan; 26(1):46-50. PubMed ID: 26787031
    [Abstract] [Full Text] [Related]

  • 5. The effects of vanadium treatment on bone in diabetic and non-diabetic rats.
    Facchini DM, Yuen VG, Battell ML, McNeill JH, Grynpas MD.
    Bone; 2006 Mar; 38(3):368-77. PubMed ID: 16256449
    [Abstract] [Full Text] [Related]

  • 6. Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats.
    Lin CY, Higginbotham DA, Judd RL, White BD.
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E1084-91. PubMed ID: 11934674
    [Abstract] [Full Text] [Related]

  • 7. Guanethidine treatment does not block the ability of central leptin administration to decrease blood glucose concentrations in streptozotocin-induced diabetic rats.
    Wang J, Wernette CM, Judd RL, Huggins KW, White BD.
    J Endocrinol; 2008 Sep; 198(3):541-8. PubMed ID: 18599620
    [Abstract] [Full Text] [Related]

  • 8. Hypoglycemic and antihyperglycemic effect of Begonia malabarica Lam. in normal and streptozotocin induced diabetic rats.
    Pandikumar P, Babu NP, Ignacimuthu S.
    J Ethnopharmacol; 2009 Jul 06; 124(1):111-5. PubMed ID: 19443148
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of chronic acarbose treatment on adipocyte insulin responsiveness, serum levels of leptin and adiponectin and hypothalamic NPY expression in obese diabetic Wistar rats.
    Pérez C, Fernández-Agulló T, De Solís AJ, Ros M, Andrés A, Carrascosa JM.
    Clin Exp Pharmacol Physiol; 2008 Mar 06; 35(3):256-61. PubMed ID: 18290871
    [Abstract] [Full Text] [Related]

  • 12. Insulin-induced immunohistochemical and morphological changes in pancreatic beta-cells of streptozotocin-treated diabetic rats.
    Adewole SO, Ojewole JA.
    Methods Find Exp Clin Pharmacol; 2007 Sep 06; 29(7):447-55. PubMed ID: 17982509
    [Abstract] [Full Text] [Related]

  • 13. Prenatal programming of skeletal development in the offspring: effects of maternal treatment with beta-hydroxy-beta-methylbutyrate (HMB) on femur properties in pigs at slaughter age.
    Tatara MR, Sliwa E, Krupski W.
    Bone; 2007 Jun 06; 40(6):1615-22. PubMed ID: 17433802
    [Abstract] [Full Text] [Related]

  • 14. Effects of insulin-like growth factor I on alveolar bone remodeling in diabetic rats.
    Fang Y, Wang LP, Du FL, Liu WJ, Ren GL.
    J Periodontal Res; 2013 Apr 06; 48(2):144-50. PubMed ID: 22834984
    [Abstract] [Full Text] [Related]

  • 15. Oral administration of phytocomponent p-hydroxycinnamic acid has a preventive effect on bone loss in streptozotocin-induced diabetic rats.
    Yamaguchi M, Uchiyama S, Lai YL.
    Int J Mol Med; 2007 May 06; 19(5):803-7. PubMed ID: 17390086
    [Abstract] [Full Text] [Related]

  • 16. Combination therapy of Nigella sativa and human parathyroid hormone on bone mass, biomechanical behavior and structure in streptozotocin-induced diabetic rats.
    Altan MF, Kanter M, Donmez S, Kartal ME, Buyukbas S.
    Acta Histochem; 2007 May 06; 109(4):304-14. PubMed ID: 17395251
    [Abstract] [Full Text] [Related]

  • 17. Long-term physical training increases liver IGF-I in diabetic rats.
    Leme JA, Silveira RF, Gomes RJ, Moura RF, Sibuya CA, Mello MA, Luciano E.
    Growth Horm IGF Res; 2009 Jun 06; 19(3):262-6. PubMed ID: 19201234
    [Abstract] [Full Text] [Related]

  • 18. The effects of co-therapy with recombinant human insulin-like growth factor I and insulin on serum leptin levels in adolescents with type 1 diabetes mellitus.
    Thrailkill KM, Fowlkes JL, Hyde JF, Litton JC.
    Pediatr Diabetes; 2001 Mar 06; 2(1):25-9. PubMed ID: 15016207
    [Abstract] [Full Text] [Related]

  • 19. Bone associated with implants in diabetic and insulin-treated rats.
    McCracken MS, Aponte-Wesson R, Chavali R, Lemons JE.
    Clin Oral Implants Res; 2006 Oct 06; 17(5):495-500. PubMed ID: 16958687
    [Abstract] [Full Text] [Related]

  • 20. Effects of chronic exercise on endothelial dysfunction and insulin signaling of cutaneous microvascular in streptozotocin-induced diabetic rats.
    Heidarianpour A, Hajizadeh S, Khoshbaten A, Niaki AG, Bigdili MR, Pourkhalili K.
    Eur J Cardiovasc Prev Rehabil; 2007 Dec 06; 14(6):746-52. PubMed ID: 18043294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.